This course has expired. View available courses.
Diabetes
GLP-1 Receptor Agonists: Once Weekly Options for the Management of Type 2 Diabetes – Canadian Council On Continuing Education In Pharmacy (CCCEP)
DURATION
PROFESSION
# OF CREDITS
1.5
ACCREDITATION
EXPIRY DATE
2017-01-12
Learning objectives
Upon completion of this program, participants will be able to:
- Describe the glucagon-like peptide 1 receptor (GLP-1R) agonists available in Canada for the treatment of type 2 diabetes.
- Compare the daily and weekly GLP-1R agonists
- Recognize clinical situations where a GLP-1R agonists could be used for patients with type 2 diabetes
- Consider patient and agent characteristics when individualizing the choice of GLP-1R agonists for patients with type 2 diabetes
- Identify and address potential barriers when advancing to injectable therapy in patients with type 2 diabetes